Literature DB >> 16406442

A rapid LC/MS/MS quantitation assay for naringin and its two metabolites in rats plasma.

Tiezheng Fang1, Yonggang Wang, Yan Ma, Weiwei Su, Yang Bai, Peiyu Zhao.   

Abstract

Naringin is a flavonoid that exists in many plants and traditional Chinese medicines. In this study, a highly sensitive and specific electrospray ionization (ESI) liquid chromatography-tandem mass spectrometry (LC/MS/MS) method was developed for quantification of naringin and its two metabolites, naringenin and naringenin glucuronide. Naringin and naringenin were extracted from rat plasma with ethyl acetate, using hesperidin as an internal standard. Components in the extract were separated on a 100 mm x 2.0 mm Betabasic 5 microm C18 ODS column by isocratic elution with 70% methanol. The components were analyzed in the multiple-reaction-monitoring (MRM) mode in the precursor/product ion pair of m/z 581.3/273.4 for naringin, m/z 273.4/153.1 for naringenin and m/z 611.5/303.4 for hesperidin, respectively. Linear calibration curves were obtained in the range of 5-1000 ng/ml, using 0.1 ml rat plasma. The within-day coefficients of variation (CVs) were 3.1, 1.8 and 2.2% for naringin, 3.0, 3.3, 3.1% for naringenin at 5, 50 and 500 ng/ml (n=5). The between-day CVs were 3.4, 1.7 and 4.9% for naringin and 4.0, 3.0, 4.6% for naringenin (n=5) at 5, 50 and 500 ng/ml respectively. A formulation based on PEG400 was used and orally administered to Sprague-Dawley male rats. Plasma drug concentrations were measured by this method and the pharmacokinetics was analyzed by WinNonlin computer software. Plasma concentration-time profiles of naringin were found to increase quickly and decline rapidly within 2 h and could not be detected after 24 h. Naringenin and naringenin glucuronide occurred slower and the T(max) were about 9 and 7.5 h later, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406442     DOI: 10.1016/j.jpba.2005.07.031

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  17 in total

1.  Identification of Naringin Metabolites in Human Urine and Feces.

Authors:  Xuan Zeng; Yang Bai; Wei Peng; Weiwei Su
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

2.  Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis.

Authors:  Jian-nong Wang; Jun-jie Jiang; Yan-ming Xie; Xu Wei; Jian-peng Li; Jing-li Duan; Xin Xiong
Journal:  Chin J Integr Med       Date:  2012-12-13       Impact factor: 1.978

3.  Synthesis of naringin 6"-ricinoleate using immobilized lipase.

Authors:  Verônica M Almeida; Carla Rc Branco; Sandra A Assis; Ivo Jc Vieira; Raimundo Braz-Filho; Alexsandro Branco
Journal:  Chem Cent J       Date:  2012-05-11       Impact factor: 4.215

4.  Prevention of disuse muscle atrophy by dietary ingestion of 8-prenylnaringenin in denervated mice.

Authors:  Rie Mukai; Hitomi Horikawa; Yutaka Fujikura; Tomoyuki Kawamura; Hisao Nemoto; Takeshi Nikawa; Junji Terao
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

5.  Comparative pharmacokinetics of naringin in rat after oral administration of chaihu-shu-gan-san aqueous extract and naringin alone.

Authors:  Shu-Qi Li; Shu Dong; Zhi-Heng Su; Hong-Wu Zhang; Jing-Bo Peng; Chang-Yuan Yu; Zhong-Mei Zou
Journal:  Metabolites       Date:  2013-09-30

6.  Systematic Analysis of Main Constituents in Rat Biological Samples after Oral Administration of the Methanol Extract of Fructus Aurantii by HPLC-ESI-MS/MS.

Authors:  Jingze Zhang; Wenyuan Gao; Zhen Liu; Zhidan Zhang; Changxiao Liu
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

7.  Exploring the Mechanism of Total Flavonoids of Drynariae Rhizoma to Improve Large Bone Defects by Network Pharmacology and Experimental Assessment.

Authors:  Weipeng Sun; Minying Li; Lei Xie; Zhexing Mai; Yan Zhang; Lieliang Luo; Zijian Yan; Zige Li; Hang Dong; Feng Huang; Zhen Shen; Ziwei Jiang
Journal:  Front Pharmacol       Date:  2021-05-31       Impact factor: 5.810

8.  New antifungal pyranoisoflavone from Ficus tikoua Bur.

Authors:  Shaopeng Wei; Wenjun Wu; Zhiqin Ji
Journal:  Int J Mol Sci       Date:  2012-06-14       Impact factor: 6.208

9.  Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction.

Authors:  Fenqin Chen; Ning Zhang; Xiaoyu Ma; Ting Huang; Ying Shao; Can Wu; Qiuyue Wang
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

10.  A Systematic Strategy for Discovering a Therapeutic Drug for Alzheimer's Disease and Its Target Molecule.

Authors:  Zhiyou Yang; Tomoharu Kuboyama; Chihiro Tohda
Journal:  Front Pharmacol       Date:  2017-06-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.